Product Detail
Product Tags
Product discription
DS-8201a, also known as trastuzumab deruxtecan (T-DXd), is an antibody-drug conjugate (ADC) designed for the treatment of HER2-positive cancers. It combines a HER2-targeting monoclonal antibody (similar to trastuzumab) with a potent topoisomerase I inhibitor (deruxtecan) as the cytotoxic payload. The drug delivers chemotherapy directly to cancer cells expressing HER2, improving efficacy while limiting damage to normal cells.
-
Category：
Cathepsin
-
Item NO.：
015200.02
-
Unit Size：
200uL,2mg/mL
-
Tissue：
N/A
-
Species：
N/A
-
Storage conditions and transportation：
Store at -70°C. Dry ice delivered.
